North Star Investment Management’s Greenwich LifeSciences GLSI Stock Holding History

North Star Investment Management’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2K	Hold	51	–	–	﹤0.01%	1509
2026 Q1	$1.23K	Hold	51	–	–	﹤0.01%	1462
2025 Q4	$1.07K	Hold	51	–	–	﹤0.01%	1386
2025 Q3	$507	Hold	51	–	–	﹤0.01%	1241
2025 Q2	$463	Hold	51	–	–	﹤0.01%	1163
2025 Q1	$487	Hold	51	–	–	﹤0.01%	1145
2024 Q4	$573	Hold	51	–	–	﹤0.01%	1167
2024 Q3	$733	Hold	51	–	–	﹤0.01%	1128
2024 Q2	$880	Hold	51	–	–	﹤0.01%	1101
2024 Q1	$1.02K	Hold	51	–	–	﹤0.01%	1155
2023 Q4	$537	Hold	51	–	–	﹤0.01%	1134
2023 Q3	$451	Hold	51	–	–	﹤0.01%	1208
2023 Q2	$492	Hold	51	–	–	﹤0.01%	1216
2023 Q1	$703	Hold	51	–	–	﹤0.01%	1206
2022 Q4	$775	Hold	51	–	–	﹤0.01%	1195
2022 Q3	$0	Hold	51	–	–	﹤0.01%	1148
2022 Q2	$0	Hold	51	–	–	﹤0.01%	1151
2022 Q1	$1K	Hold	51	–	–	﹤0.01%	1101
2021 Q4	$1K	Hold	51	–	–	﹤0.01%	1129
2021 Q3	$2K	Hold	51	–	–	﹤0.01%	1035
2021 Q2	$2K	Hold	51	–	–	﹤0.01%	1017
2021 Q1	$2K	Buy	+51	New	+$1.74K	﹤0.01%	973

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

North Star Investment Management's GLSI Position: Q2 2026 in Review

North Star Investment Management held its Greenwich LifeSciences (GLSI) position steady in Q2 2026 at 51 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1509.

North Star Investment Management first reported a position in GLSI in Q1 2021 and has held it in 22 quarters since. The position peaked at $2K in Q3 2021. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

North Star Investment Management held 51 shares of Greenwich LifeSciences worth $1.2K as of Q2 2026.
North Star Investment Management left its Greenwich LifeSciences share count unchanged in Q2 2026.
Greenwich LifeSciences made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1509 holding.
North Star Investment Management first reported a position in Greenwich LifeSciences in Q1 2021 and has held it in 22 quarters since.
North Star Investment Management's Greenwich LifeSciences position peaked at $2K in Q3 2021.
57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.